| Term 
 
        | How often should fasting lipid profile be obtained in adults? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Four groups of patients most likely to benefit from statin therapy? |  | Definition 
 
        | 1. Age 40-75 w/ DM and LDL-C of 70-189mg/dL 2. PMH of ASCVD
 3. Age 40-75 w/ 10-yr ASCVD score of ≥7.5% and LDL-C 70-189 mg/dL
 4. LDL-C ≥190mg/dL
 |  | 
        |  | 
        
        | Term 
 
        | 10-year ASCVD risk score should be calculated for patients with LDL-C level of? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | High intensity statin age cut-off is |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | List high intensity statins (brand/generic) and dose ranges (two drugs) |  | Definition 
 
        | Atorvastatin (Lipitor) 40-80mg Qday Rosuvastatin (Crestor) 20-40mg Qday
 |  | 
        |  | 
        
        | Term 
 
        | High intensity statins lower LDL-C by _______% while moderate intensity statins lower LDL-C by ________% |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bile acid resins: Brand/generic (3 drugs) |  | Definition 
 
        | *Colesevelam | Welchol * = on Top 200 List
 Cholestyramine | Prevalite
 Colestipol | Colestid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Binds to bile acids forming insoluble complex that is excreted.  This causes the liver to convert cholesterol into bile acids which decreases cholesterol stores.  Liver then sends demand for more cholesterol resulting in the upregulation of LDL receptors and increased clearance of LDL-C from bloodstream. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Every GI issue imaginable Increased TGs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Binds to and decr. absorption of many drugs like: warfarin, digoxin, thiazides, levothyroxine, and mycophenolate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incr TGs Decr LDL-C
 Safe for liver disease pts
 Colesevelam (Welchol) has least GI SEs
 Do NOT admin w/ other meds. Take other meds 1hr before or 4hr after
 Admin w/ food
 Fiber supps may reduce GI SE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Decr production of VLDL in liver resulting in decr production of LDL-C |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Liver disease Active gout
 Active PUD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Flushing/itching Nausea
 Orthostatic hypotension
 Incr LFTs
 Myopathy
 Hyperuricemia
 Hypergylcemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Most effective drug for incr HDL-C Decr LDL-C and TGs
 Incr dose by <500mg Q4wk
 PM dosing so flushing occurs while asleep
 Take 325mg aspirin/NSAID 30 min prior to reduce flushing
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Niaspan * = On Top 200 Drug List
 |  | 
        |  | 
        
        | Term 
 
        | Fibric Acid Derivatives: brand generic |  | Definition 
 
        | fenofibrate/fenofibric acid | Tricor, Fibricor, Lipofen, Triglide, Trilipix, Antara, Fenoglide Gemfibrozil | Lopid
 |  | 
        |  | 
        
        | Term 
 
        | Fibric Acid Derivatives: CIs |  | Definition 
 
        | Hepatic impairment Renal impairment (severe)
 Gall bladder disease
 
 Gemfibrozil (Lopid) Only: Concurrent use with: statins, repaglinide, dasabuvir, selexipag
 |  | 
        |  | 
        
        | Term 
 
        | Fibric Acid Derivatives: SEs |  | Definition 
 
        | N/V/D Ab pain
 Incr LFT
 Myopathy
 Severe rash
 Anaphylaxis/angioedema
 |  | 
        |  | 
        
        | Term 
 
        | Fibric Acid Derivatives: DIs |  | Definition 
 
        | Gemfibrozil (Lopid) only: - CYP28 inhibitor
 - Use with statins incr myopathy risk
 - Use w/ repaglinide incr hypoglycemia risk
 - Use with dasabuvir incr QT prolongation risk
 
 Incr  effects of warfarin and SUs
 Decr cyclosporine effects
 |  | 
        |  | 
        
        | Term 
 
        | Fibric Acid Derivatives: Pearls |  | Definition 
 
        | Decr TGs Incr HDL-C
 Fenofibrate preferred if using w/ statins
 Adust dose for renal function
 Admin with meals to decr GI SEs
 |  | 
        |  | 
        
        | Term 
 
        | Omega-3 Fatty Acids (Fish Oil): brand/generic (2 drugs) |  | Definition 
 
        | lcosapent ethyl | Vascepa Omega-3-Acid ethyl esters | Lovaza
 |  | 
        |  | 
        
        | Term 
 
        | Omega-3 Fatty Acids (Fish Oil): SEs (lcosapent (Vascepa)) only |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Omega-3 Fatty Acids (Fish Oil): DIs |  | Definition 
 
        | Incr bleed risk when used with antithrombotic agents |  | 
        |  | 
        
        | Term 
 
        | Omega-3 Fatty Acids (Fish Oil):Pearls |  | Definition 
 
        | Decr TGs Incr LDL-C (maybe)
 Take lcosapent (Vascepa) w/ meals
 |  | 
        |  | 
        
        | Term 
 
        | Omega-3 Fatty Acids (Fish Oil): MOA |  | Definition 
 
        | Decr production of TGs in liver |  | 
        |  | 
        
        | Term 
 
        | Fibric Acid Derivatives: MOA |  | Definition 
 
        | Incr activity of lipoprotein lipase leading to ice breakdown of VLDL and decr in TGs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits HMG-COA reductase preventing conversion of HMG-CoA to mevalonate (rate limiting step in cholesterol synthesis) |  | 
        |  | 
        
        | Term 
 
        | Statins: Brand/generic Top 200 (5 drugs) |  | Definition 
 
        | *atorvastatin | Lipitor (H) *rosuvastatin | Crestor (H)
 *lovastatin | Altoprev
 *pravastatin | Pravachol
 *simvastatin | Zocor, Flolipid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Liver disease Pregnancy
 Use of atorvastatin + cyclosporine
 Use of lovastatin + 3A4 inhibitors
 Use of simvastatin + CYP3A4 inhibitors, cyclosporine and/or danazol
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incr LFTs myopathy
 N/V
 constipation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Atorvastatin, simvastatin, and lovastatin are 3A4 substrates Fluvastatin and pitavastin are 2C9 substrates
 **Pravastatin is NOT metabolized by CYP enzymes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beware of interactions! Most effective drug for decr LDL-C
 Simvastatin also avaliable as oral suspension (FloLipid)
 Admin in evening to coincide with cholesterol prod, timing
 Adj pitavistatin and rosuvastatin for renal function
 |  | 
        |  | 
        
        | Term 
 
        | Lower maximum atorvastatin (Lipitor) dose when administered with which drugs? |  | Definition 
 
        | clarithromycin darunavir/ritonavir
 fosamprenavir
 fosamprenavir/ritonavir
 itraconazole
 nelfinavir
 saquinavir/ritonavir
 |  | 
        |  | 
        
        | Term 
 
        | Lower maximum fluvastatin (Lescol XL) dose when administered with which drugs |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lower maximum lovastatin (Altoprev) dose when administered with which drugs |  | Definition 
 
        | amiodoraone droneadrone
 verapamil
 diltiazem
 danazol
 lomitapide
 |  | 
        |  | 
        
        | Term 
 
        | Lower maximum pravastain (Pravachol) dose when administered with which drugs |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lower maximum rosuvastatin (Crestor) dose when administered with which drugs |  | Definition 
 
        | cyclosporine gemfibrozil
 lopinavir/ritonavir
 atazanavir/ritonavir
 semiprevir
 |  | 
        |  | 
        
        | Term 
 
        | Lower maximum simvastain (Zocor) dose when administered with which drugs? |  | Definition 
 
        | amiodoraone amlodipine
 diltiazem
 droneadrone
 niacin
 ranolazine
 verapamil
 lomitapide
 |  | 
        |  | 
        
        | Term 
 
        | Statins: combo drug (1 drug) |  | Definition 
 
        | simvastatin/ezetimibe | Vytorin |  | 
        |  | 
        
        | Term 
 
        | Cholesterol Absorption Inhibitors: brand/generic (1 drug) |  | Definition 
 
        | *ezetimibe | Zetia * = on Top 200 Drug List
 |  | 
        |  | 
        
        | Term 
 
        | Cholesterol Absorption Inhibitors: SE |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholesterol Absorption Inhibitors: CI |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholesterol Absorption Inhibitors: DI |  | Definition 
 
        | inc effects of warfarin incr levels of cyclosporine
 cyclosporine + fibrates incr effects of ezetimibe (Zetia)
 |  | 
        |  | 
        
        | Term 
 
        | Cholesterol Absorption Inhibitors: pearls |  | Definition 
 
        | decr LDL-C Can be ADD-ON to statin
 |  | 
        |  | 
        
        | Term 
 
        | Cholesterol Absorption Inhibitors: MOA |  | Definition 
 
        | Prevents absorption of cholesterol in small intestine |  | 
        |  | 
        
        | Term 
 
        | 4 facts about lomitapide (Juxtapid); the onle MTP inhibitor |  | Definition 
 
        | REMS program DO NOT use if pregnant
 3A4 substrate
 Must take with a daily vitamin supp.
 |  | 
        |  | 
        
        | Term 
 
        | PCSK9 inhibitors: Storage |  | Definition 
 
        | Keep refrigerated alirocumab (Praluent) can be kept at room temp for 30d if reqd
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits binding of PCSK9 to LDL receptors on hepatocytes which increases the # of receptors avaliable to clear LDL from blood stream lowering LDL-C |  | 
        |  | 
        
        | Term 
 
        | PCSK9 inhibitors: brand/generic (two drugs) |  | Definition 
 
        | arlirocumab | Praluent evolocumab | Reptha
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | alrirocumab only: diarrhea
 incr LFTs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |